A study in breast cancer survivors receiving cyclophosphamide-based therapy by Su et al. evaluated time to chemotherapy-related ovarian failure and the effect of five SNPs in CYP3A4, CYP2B6, and CYP3A5. The gene discussed is CYP3A4; the disease is breast carcinoma.